- Home
- TXN vs BSX Comparison
TXN vs BSX Comparison
Compare TXN & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXN
- BSX
- Stock Information
- Founded
- TXN 1930
- BSX 1979
- Country
- TXN United States
- BSX United States
- Employees
- TXN N/A
- BSX N/A
- Industry
- TXN Semiconductors
- BSX Medical/Dental Instruments
- Sector
- TXN Technology
- BSX Health Care
- Exchange
- TXN Nasdaq
- BSX Nasdaq
- Market Cap
- TXN 174.0B
- BSX 157.6B
- IPO Year
- TXN N/A
- BSX 1992
- Fundamental
- Price
- TXN $180.32
- BSX $97.31
- Analyst Decision
- TXN Buy
- BSX Strong Buy
- Analyst Count
- TXN 26
- BSX 22
- Target Price
- TXN $218.24
- BSX $121.18
- AVG Volume (30 Days)
- TXN 7.2M
- BSX 12.3M
- Earning Date
- TXN 10-21-2025
- BSX 10-22-2025
- Dividend Yield
- TXN 3.02%
- BSX N/A
- EPS Growth
- TXN N/A
- BSX 36.90
- EPS
- TXN 5.47
- BSX 1.68
- Revenue
- TXN $16,675,000,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- TXN $14.12
- BSX $19.85
- Revenue Next Year
- TXN $10.24
- BSX $11.07
- P/E Ratio
- TXN $32.97
- BSX $57.92
- Revenue Growth
- TXN 3.62
- BSX 21.44
- 52 Week Low
- TXN $139.95
- BSX $80.64
- 52 Week High
- TXN $221.69
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- TXN 40.46
- BSX 36.80
- Support Level
- TXN $178.33
- BSX $90.69
- Resistance Level
- TXN $187.29
- BSX $99.01
- Average True Range (ATR)
- TXN 4.02
- BSX 2.49
- MACD
- TXN 0.43
- BSX -0.14
- Stochastic Oscillator
- TXN 30.37
- BSX 71.11
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.